Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sutherlandia frutescens, commonly known as "Cancer Bush" or "Kankerbos," is a medicinal plant native to Southern Africa with a long history of use in traditional medicine. It contains a variety of bioactive compounds, including L-canavanine, pinitol, GABA, and various flavonoids. Research indicates that the plant possesses neuroprotective, anti-inflammatory, and antioxidant properties. In preclinical studies, such as those using rotenone-induced rat models, Sutherlandia frutescens has shown potential in mitigating motor deficits and activating hippocampal neuronal activity, suggesting a possible role in the management of Parkinson's disease. It has also been clinically investigated for its safety and efficacy in patients with HIV/AIDS and type 2 diabetes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sutherlandia frutescens.